Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2020-08, Vol.73, p.S116-S117
Main Authors: Loomba, Rohit, Noureddin, Mazen, Kowdley, Kris, Kohli, Anita, Sheikh, Aasim, Neff, Guy, Bhandari, Bal Raj, Gunn, Nadege T., Caldwell, Stephen, Goodman, Zachary, Wapinski, Ilan, Resnick, Murray, Beck, Andrew, Ding, Dora, Jia, Catherine, Huss, Ryan, Chung, Chuhan, Subramanian, Mani, Myers, Robert, Patel, Keyur, Borg, Brian, Ghalib, Reem, Kabler, Heidi, Poulos, John, Younes, Ziad H., Elkhashab, Magdy, Hassanein, Tarek, Iyer, Rajalakshmi, Ruane, Peter, Shiffman, Mitchell, Strasser, Simone, Wong, Vincent Wai-Sun, Alkhouri, Naim
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
DOI:10.1016/S0168-8278(20)30753-4